Efficacy and safety of moderately steatotic donor liver in transplantation

Hepatobiliary and Pancreatic Diseases International

Volumn 8, Issue 1, 2009, Pages 29-33

  Gao, Feng ^a   Xu, Xiao ^a   Ling, Qi ^a   Wu, Jian ^a   Zhou, Lin ^a   Xie, Hai Yang ^a   Wang, Hui Ping ^a   Zheng, Shu Sen ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Liver function; Liver steatosis; Liver transplantation; Survival

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FATTY LIVER; FEMALE; GRAFT DYSFUNCTION; HUMAN; KIDNEY FUNCTION; KIDNEY INJURY; LIVER FUNCTION; LIVER TRANSPLANTATION; MALE; ORGAN DONOR; OUTCOME ASSESSMENT; SAFETY; SURVIVAL RATE; SURVIVAL TIME;

ADULT; CADAVER; FATTY LIVER; FEMALE; GRAFT SURVIVAL; HUMANS; KAPLAN-MEIERS ESTIMATE; LIVER; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; ORGAN SIZE; SEVERITY OF ILLNESS INDEX; TISSUE DONORS; TREATMENT OUTCOME;

EID: 60549107860     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Wu J, Zheng SS. Liver transplantation in China: problems and their solutions. Hepatobiliary Pancreat Dis Int 2004;3: 170-174.
2. Verran D, Kusyk T, Painter D, Fisher J, Koorey D, Strasser S, et al. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transpl 2003;9:500-505.
3. Briceno J, Padillo J, Rufián S, Solórzano G, Pera C. Assignment of steatotic livers by the Mayo model for end-stage liver disease. Transpl Int 2005;18:577-583.
4. Gruttadauria S, Cintorino D, Mandala' L, Musumeci A, Volpes R, Vizzini GB, et al. Acceptance of marginal liver donors increases the volume of liver transplant: early results of a single-center experience. Transplant Proc 2005;37:2567-2568.
5. Chui AK, Haghighi K, Painter D, Jayasundera M, Hall G, Rao AR, et al. Donor fatty (steatotic) liver allografts in orthotopic liver transplantation. Transplant Proc 1998;30: 3286-3287.
6. Fishbein TM, Fiel MI, Emre S, Cubukcu O, Guy SR, Schwartz ME, et al. Use of livers with microvesicular fat safely expands the donor pool. Transplantation 1997;64: 248-251.
7. D'Alessandro AM, Kalayoglu M, Sollinger HW, Hoffmann RM, Reed A, Knechtle SJ, et al. The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. Transplantation 1991; 51:157-163.
8. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33:464-470.
9. Deschênes M, Belle SH, Krona RA, Zetterman RK, Lake JR. Early allograft dysfunction after liver transplantation: a definition and predictors of outcome. National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Transplantation 1998;66:302-310.
10. Gainza FJ, Valdivieso A, Quintanilla N, Errazti G, Gastaca M, Campo M, et al. Evaluation of acute renal failure in the liver transplantation perioperative period: incidence and impact. Transplant Proc 2002;34:250-251.
11. Busuttil RW, Tanaka K. The Utility of marginal donors in liver transplantation. Liver Transpl 2003;9:651-663.
12. Nikeghbalian S, Nejatollahi SM, Salahi H, Bahador A, Sabet B, Jalaeian H, et al. Does donor's fatty liver change impact on early mortality and outcome of liver transplantation. Transplant Proc 2007;39:1181-1183.
13. Koneru B, Dikdan G. Hepatic steatosis and liver transplantation current clinical and experimental perspectives. Transplantation 2002;73:325-330.
14. Todo S, Demetris AJ, Makowka L, Teperman L, Podesta L, Shaver T, et al. Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation 1989;47: 903-905.
15. Briceno J, Marchal T, Padillo J, Solórzano G, Pera C. Influence of marginal donors on liver preservation injury. Transplantation 2002;74:522-526.
16. Chen H, Peng CH, Shen BY, Deng XX, Shen C, Xie JJ, et al. Multi-factor analysis of initial poor graft function after orthotopic liver transplantation. Hepatobiliary Pancreat Dis Int 2007;6:141-146.
17. Adam R, Reynes M, Johann M, Morino M, Astarcioglu I, Kafetzis I, et al. The outcome of steatotic grafts in liver transplantation. Transplant Proc 1991;23:1538-1540.
18. Ijaz S, Yang W, Winslet MC, Seifalian AM. Impairment of hepatic microcirculation in fatty liver. Microcirculation 2003;10:447-456.
19. Seifalian AM, Piasecki C, Agarwal A, Davidson BR. The effect of graded steatosis on flow in the hepatic parenchymal microcirculation. Transplantation 1999;68:780-784.
20. Fukumori T, Ohkohchi N, Tsukamoto S, Satomi S. The mechanism of injury in a steatotic liver graft during cold preservation. Transplantation 1999;67:195-200.
21. Avolio AW, Agnes S, Nure E, Gasbarrini A, Siciliano M, Pompili M, et al. The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient. Transplant Proc 2006;38: 1055-1058.
22. Angele MK, Rentsch M, Hartl WH, Wittmann B, Graeb C, Jauch KW, et al. Effect of graft steatosis on liver function and organ survival after liver transplantation. Am J Surg 2008;195:214-220.
23. Tekin K, Imber CJ, Atli M, Gunson BK, Bramhall SR, Mayer D, et al. A simple scoring system to evaluate the effects of cold ischemia on marginal liver donors. Transplantation 2004;77:411-416.